A total of 173 (70.9%) patients had advanced cancer (Stage II and III) with only a minority diagnosed with Stage I. The mean ± SD level of cancer antigen (CA15-3) was 15.7 ± 5.36 U/ml and of CEA was 1.7 ± 1.1 ng/ml. The gene discussed is CEACAM5; the disease is cancer.